The company's patented technology enables physicians to screen large patient populations for epidemically spreading metabolic disorders by analyzing the ability of sweat glands to release chloride ions in response to an electrochemical stimulus, thus detecting diseases and complications at an early stage. Impeto Medical has two subsidiaries in China and the US, and more information can be found on their website.